Recent news on Daunorubicin

Food warnings used too heavily lose zest  -  May 5, 2007
The Spokesman Review,...now more than 750 substances, some as venerably villainous as arsenic and mercury, and some as obscure as the antibiotic daunorubicin hydrochloride,

Gemtuzumab Induction Therapy Improved Progression Free Survival ...  -  Dec 14, 2006
DG NewsIn the study, patients were treated with gemtuzumab in addition to 1 of 3 standard chemotherapy regimens: 1. daunorubicin and cytarabine; 2. cytarabine ...

Market Report -- In Play (BIVN)  -  Dec 11, 2006
MSN Money...for LDAC. A dose-ranging study assessing the combination of Evoltra and daunorubicin showed an overall response rate of 65%. In ...

Bioenvision Unveils Latest Results From Clinical Studies of ...  -  Dec 11, 2006
New Age Media Concepts (press release)...(Abstract 1985; Poster 163). A dose-ranging study assessing the combination of Evoltra ® and daunorubicin showed an overall response rate of 65%. ...

Study: Long anthracycline therapy better  -  Dec 7, 2006
Monsters and Critics.com,Dr. Elvira van Dalen and colleagues at the Emma Children`s Hospital in the Netherlands studied anthracycline drugs, such as daunorubicin and doxorubicin, that ...

Reducing heart problems for chemo patients  -  Nov 27, 2006
United Press International...on cancer patients with a variety of malignancies who received both long and short infusions of anthracyclines, including daunorubicin (Cerubidine) and ...

Longer anthracycline therapy reduces heart failure in adult cancer ...  -  Nov 27, 2006
innovations report,Anthracycline drugs like daunorubicin and doxorubicin are used to treat many types of solid tumors and blood cancers such as leukemias in adults and children. ...

Longer infusion times for anthracyclines reduce cardiac damage  -  Nov 29, 2006
TheHeart.Org,The majority of patients were adults with different types of solid tumors, and the drugs used were doxorubicin, daunorubicin, and epirubicin. ...

Pharmion Acquires Cabrellis Pharmaceuticals  -  Dec 4, 2006
Pharmaceutical Online (press release),This class of drug includes doxorubicin, daunorubicin and epirubicin, each of which is a close analogue to the others and made semi-synthetically starting from ...

Prolonging the dose of cancer chemotherapy can reduce side effects  -  Dec 1, 2006
HealthandAge.comAnthracycline therapy, which includes drugs like daunorubicin and doxorubicin, is effective in treating solid tumors and blood cancer. ...

Bioenvision Announces Latest Data on Evoltra(R) in Pediatric and ...  -  Dec 10, 2006
Genetic Engineering News (press release),...(Abstract 1985; Poster 163). -- A dose-ranging study assessing the combination of Evoltra(R) and daunorubicin showed an overall response rate of 65%. ...

Bioenvision’s Evoltra ® Data Selected for Oral Presentation at ...  -  Dec 4, 2006
Business Wire (press release),...in Refractory and Relapsed Childhood Acute Lymphoblastic Leukemia Poster Board #37-II Abstract 1950 The Feasibility of Combining Daunorubicin, Clofarabine and ...

Study shows prolonging chemotherapy may reduce cardiac risk  -  Nov 23, 2006
Pharmaceutical Business ReviewAnthracycline drugs like daunorubicin and doxorubicin are used to treat many types of solid tumors and blood cancers such as leukemias. ...

Genta: Patient Accrual Completed Into Phase 3 Trial Of Genasense ...  Oct 31, 2006
In this trial, all patients received standard chemotherapy with daunorubicin and cytarabine (ARA-C | charts | news | PowerRating), and they were randomly ... -Trading Markets, Diatos Strengthens Management Team with the Appointment of New ...  Oct 9, 2006
DaunoXome ® , a liposomal formulation of widely used cancer drug daunorubicin, improves the biodistribution of daunorubicin and fosters its sustained ... -Business Wire (press release), Patient Accrual Completed Into Phase 3 Trial Of Genasense(R) In ...  Nov 1, 2006
In this trial, all patients received standard chemotherapy with daunorubicin and cytarabine (ARA-C), and they were randomly assigned to receive Genasense or no ... -Medical News Today (press release), Diatos versterkt managementteam  Oct 9, 2006
About Diatos' Portfolio -- DaunoXome(R), a liposomal formulation of widely used cancer drug daunorubicin, improves the biodistribution of daunorubicin and ... -Netherlands Corporate News (persbericht), Patient Accrual Completed into Phase 3 Trial of Genasense(R) in ...  Oct 31, 2006
In this trial, all patients received standard chemotherapy with daunorubicin and cytarabine (ARA-C), and they were randomly assigned to receive Genasense or no ... -Earthtimes.org Patient Accrual Completed into Phase 3 Trial of Genasense(R) in ...  Oct 31, 2006
...forward to evaluating these results with our colleagues in CALGB." In this trial, all patients received standard chemotherapy with daunorubicin and cytarabine ... -PR Newswire (press release), Buzz Products Chief Faces Death's Approach  Sep 11, 2006
...said. Tefferi recommended a drug called Daunorubicin, which wasnt covered by insurance. ... success. He said they dont use Daunorubicin. ... -International News Service

Study: Long Anthracycline Therapy Better  -  Dec 7, 2006
Playfuls.com,Dr. Elvira van Dalen and colleagues at the Emma Children's Hospital in the Netherlands studied anthracycline drugs, such as daunorubicin and doxorubicin,

Prolonging the dose of cancer chemotherapy can reduce side effects  -  Dec 1, 2006
HealthandAge.comAnthracycline therapy, which includes drugs like daunorubicin and doxorubicin, is effective in treating solid tumors and blood cancer.

Study shows prolonging chemotherapy may reduce cardiac risk  -  Nov 23, 2006
Pharmaceutical Business ReviewAnthracycline drugs like daunorubicin and doxorubicin are used to treat many types of solid tumors and blood cancers such as leukemias.

Pharmion Acquires Cabrellis Pharmaceuticals  -  Dec 4, 2006
Pharmaceutical Online (press release),This class of drug includes doxorubicin, daunorubicin and epirubicin, each of which is a close analogue to the others and made semi-synthetically starting

Bioenvision’s Evoltra ® Data Selected for Oral Presentation at ASH ...  -  Dec 4, 2006
Business Wire (press release),Leukemia Poster Board #37-II Abstract 1950 The Feasibility of Combining Daunorubicin, Clofarabine and Gemtuzumab Ozogamicin Is Feasible and Effective.

Longer infusion times for anthracyclines reduce cardiac damage  -  Nov 29, 2006
TheHeart.Org,The majority of patients were adults with different types of solid tumors, and the drugs used were doxorubicin, daunorubicin, and epirubicin.

Reducing heart problems for chemo patients  -  Nov 27, 2006
United Press International...variety of malignancies who received both long and short infusions of anthracyclines, including daunorubicin (Cerubidine) and doxorubicin (Adriamycin).

Pharmion Acquires Cabrellis: $59M For Lung Cancer Drug  -  Nov 16, 2006
BioWorld Online,...which let Dainippon scientists make changes that will distinguish it from the likes of doxorubicin, daunorubicin and epirubicin, LeMasters said,

Pharmion Acquires Cabrellis Pharmaceuticals, Gains Rights to ...  -  Nov 15, 2006
Earthtimes.orgThis class of drug includes doxorubicin, daunorubicin andepirubicin, each of which is a close analogue to the others and madesemi-synthetically starting

Pharmion Acquires Cabrellis Pharmaceuticals, Gains Rights to ...  -  Nov 15, 2006
Earthtimes.orgThis class of drug includes doxorubicin, daunorubicin and epirubicin, each of which is a close analogue to the others and made semi- synthetically starting

Cabrellis' $27.5M Series A To Fund Three SCLC Trials  Aug 7, 2006
...better because it appears to "exert more [topoisomerase II] activity than traditional anthracyclines," which include doxorubicin, daunorubicin and epirubicin ... -BioWorld Online

Nanoparticles May Play a Role in Inhibiting the Multidrug ...  Jul 5, 2006
...of the synergistic effect of three kinds of magnetic nanoparticles, nano Fe3O4, Ni and Fe2O3, on the drug uptake of anticancer drug daunorubicin in leukemia ... -Newswire Today

Celator Pharmaceuticals Announces Positive European Patent ...  Jul 17, 2006
CPX-351 is a synergistic fixed ratio combination of cytarabine and daunorubicin in development as a potential treatment for acute myeloid leukemia. ... -Yahoo! News

Ecopia Announces Operating Highlights and Financial Results for ...  Jul 11, 2006
Just like well-known chemotherapies such as doxorubicin and daunorubicin, ECO-4601 comes from microorganisms that live in common soil. ... -Market Wire

Lenograstim Effective After Consolidation Chemotherapy for Elderly ...  Jun 21, 2006
...newly diagnosed de novo AML (except M3, by the French-American-British [FAB] criteria), complete remission after induction therapy with daunorubicin (DNR) and ... -DG News



Diatos koopt kankermedicijn DaunoXome van Gilead Sciences  May 11, 2006
Gilead Sciences Pharmaceutical Writers/Business Editors/Biotech Writers PARIS--(BUSINESS WIRE)--May 11, 2006-- DaunoXome (liposomal daunorubicin) is indicated ... - Netherlands Corporate News (persbericht)

Diatos Announces Acquisition of Specialty Cancer Product DaunoXome ...  May 11, 2006
DaunoXome is a marketed liposomal formulation of daunorubicin, which has been approved for AIDS/HIV-related Kaposi's sarcoma and is sold by Gilead in more than ... - PharmaLive.com

French biotech Diatos buys DaunoXome rights from Gilead  May 11, 2006
DaunoXome is a marketed liposomal formulation of daunorubicin, which has been approved for AIDS/HIV-related Kaposi's sarcoma and is sold by Gilead in more than ... - MarketWatch

Diatos licenses Gilead anticancer drug  May 12, 2006
DaunoXome, liposomal formulation of daunorubicin, is already sold by Gilead in more than 20 countries for AIDS/HIV-related Kaposi's sarcoma. ... - Pharmaceutical Business Review





Positive results for Bioenvision's Evoltra  Apr 7, 2006
...treatment Evoltra. The study used a combination of Evoltra (clofarabine) with the traditional chemotherapy agent daunorubicin. Results ... - Pharmaceutical Business Review

Bioenvision's Evoltra(R) Achieves High Response Rates in Adult AML ...  Apr 5, 2006
...been achieved in 92% of patients over 60 yrs of age with acute myeloid leukemia (AML) given a combination of Evoltra(R) (clofarabine) and daunorubicin as first ... - Genetic Engineering News

Bioenvision Reports Evoltra Shows Significant Response Rates In ...  Apr 5, 2006
...trials has achieved overall response in 92% of patients over 60 yrs of age who were given a combination of Evoltra (clofarabine) and daunorubicin as first-line ... - Trading Markets

Bioenvision Posts Promising Evoltra Data  Apr 5, 2006
So far, the company found that 11 out of 12 patients receiving a combination of Evoltra and the chemotherapy daunorubicin as first-line treatment showed a ... - Houston Chronicle

Bioenvision Says Its Evoltra Achieves High Response Rates In Adult ...  Apr 5, 2006
...an overall response had been achieved in 92% of patients over 60 yrs of age with acute myeloid leukemia given a combination of Evoltra and daunorubicin as first ... - Trading Markets

Callisto Pharma Expands Research Trial Of Cancer Drug L-Annamycin ...  Mar 21, 2006
...drugs in clinical use today. Compounds in this class include doxorubicin, daunorubicin and epirubicin. These drugs are all close ... - Trading Markets

Anthracyclines Linked with Damage to Blood Vessels  Feb 24, 2006
These drugs, which include doxorubicin and daunorubicin, are used to treat a variety of cancers, including Hodgkin’s lymphoma, sarcomas, and breast cancer. ... - Cancer Consultants,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional